Steve Laflin
Net worth: 1 M $ as of 2026-05-30
Net worth: 1 M $ as of 2026-05-30
Steve T.
Laflin is Chief Executive Officer at RadQual LLC since 2021.
Mr. Laflin is Director at Radnostix, Inc. since 2023.
Mr. Laflin was President & Chief Executive Officer at International Isotopes Idaho, Inc. from 1996 to 2001.
Mr. Laflin completed undergraduate studies at Idaho State University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
RADNOSTIX, INC. 2.42% | 2026-05-25 | 12,786,700 ( 2.42% ) | 1 M $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| RADNOSTIX, INC. | Director/Board Member | 2001-05-31 |
RadQual LLC
RadQual LLC Medical SpecialtiesHealth Technology Manufactures quality control products for the nuclear medicine and PET imaging communities | Chief Executive Officer | 2021-06-30 |
| Companies | Position | End |
|---|---|---|
International Isotopes Idaho, Inc.
International Isotopes Idaho, Inc. Pharmaceuticals: MajorHealth Technology Produces and supplies radioisotopes and brachytherapy for the treatment of cancer | Chief Executive Officer | 2000-12-31 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
Radnostix, Inc.
Radnostix, Inc. Medical SpecialtiesHealth Technology Manufactures finished radiopharmaceuticals, pharmaceutical grade radiochemical, radioisotopes, brachytherapy medical devices | Health Technology |
Idaho State University
Idaho State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RadQual LLC
RadQual LLC Medical SpecialtiesHealth Technology Manufactures quality control products for the nuclear medicine and PET imaging communities | Health Technology |
International Isotopes Idaho, Inc.
International Isotopes Idaho, Inc. Pharmaceuticals: MajorHealth Technology Produces and supplies radioisotopes and brachytherapy for the treatment of cancer | Health Technology |
Select your edition
All financial news and data tailored to specific country editions